Skip to main content

Table 1 Characteristics of included patients

From: COVID-19 screening before gastrointestinal procedures

Age
Mean ± SD (range)
46.11 ± 17.16 (15 – 80)
Gender
 Males 60 (58.25%)
 Females 43 (41.75%)
Performed procedure
 Esophago-gastro duodenoscopy (OGD) 44 (42.7%)
 Percutaneous endoscopic gastrostomy (PEG) tube insertion 1 (0.97%)
 Colonoscopy 25 (24.27%)
 Enteroscopy 1 (0.97%)
 Endoscopic retrograde cholangiopancreatography (ERCP) 12 (11.65%)
 Endoscopic ultrasound (EUS) 7 (6.8%)
 Pigtail 3 (2.9%)
 Percutaneous transhepatic drainage (PTD) 2 (1.94%)
 Liver biopsy 2 (1.94%)
 Radiofrequency ablation (RFA) 3 (2.9%)
 Trans-arterial chemoembolization (TACE) 3 (2.9%)
Procedure emergency
 Urgent 24 (23.3%)
 Semi-urgent 28 (27.2%)
 Elective 51 (49.5%)
COVID-19-related symptomatic 3 (2.9%)
 Fever ≥38°C only 1 (0.97%)
 Fever ≥ 38°C with dyspnea 1 (0.97%)
 Fever ≥ 38°C with diarrhea 1 (0.97%)
Associated comorbidity
 Diabetes mellitus 13 (12.6%)
 Hypertension 8 (7.76%)
History of contact with COVID-19 patients
 Yes 0 (0%)
 No 103 (100%)
Laboratory tests
 Lymphopenia 16 (11.1%)
 Elevated CRP 25 (24.3%)
Chest CT findings of COVID-19 pneumonia
 Yes 2 (1.9%)
 No 101 (98.1%)
COVID-19 antibody
 IgM-positive 7 (6.8%)
 IgG-positive 8 (7.8%)
 IgM and IgG-positive 11 (10.7%)
 IgM and IgG-negative 77 (74.7%)
COVID-19 PCR (n=26)
Positive 16 (61.5%)
Negative 10 (38.5%)
COVID-19 infection after the procedures based on symptoms
 Yes 0 (0%)
 No 103 (100%)